We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $43.3B
1-Year Est. Return 29.3%
This Fund
S&P 500
This Quarter Est. Return
+17.09%
1 Year Est. Return
+29.3%
3 Year Est. Return
+83.12%
5 Year Est. Return
+90.93%
10 Year Est. Return
+282.52%
AUM
$43.3B
AUM Growth
+$4.47B
Cap. Flow
-$120M
Cap. Flow %
-0.28%
Top 10 Hldgs %
19.72%
Holding
4,210
New
286
Increased
1,913
Reduced
1,499
Closed
436

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 4.34%
3 Industrials 3.63%
4 Consumer Discretionary 3.11%
5 Communication Services 2.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLI
3726
Standard Lithium
SLI
$493M
$39K ﹤0.01%
14,057
-107
-0.8% -$389
TCPC icon
3727
BlackRock TCP Capital
TCPC
$274M
$39K ﹤0.01%
11,576
-8,419
-42% -$32.7K
WTI icon
3728
W&T Offshore
WTI
$473M
$39K ﹤0.01%
12,505
AVXL icon
3729
Anavex Life Sciences
AVXL
$238M
$36K ﹤0.01%
13,960
-1,000
-7% -$2.96K
EU
3730
enCore Energy
EU
$223M
$36K ﹤0.01%
27,574
+7,379
+37% +$12.4K
ALT icon
3731
Altimmune
ALT
$581M
$34K ﹤0.01%
11,206
DOUG icon
3732
Douglas Elliman
DOUG
$160M
$33K ﹤0.01%
18,922
-1,876
-9% -$3.36K
QSI icon
3733
Quantum-Si Incorporated
QSI
$166M
$33K ﹤0.01%
37,809
-4,000
-10% -$3.81K
LASE icon
3734
Laser Photonics
LASE
$52.2M
$30K ﹤0.01%
+18,409
New +$25.3K
CLNE icon
3735
Clean Energy Fuels
CLNE
$421M
$28K ﹤0.01%
13,504
+1,520
+13% +$3.23K
BIVI icon
3736
BioVie
BIVI
$10M
$27K ﹤0.01%
+13,816
New +$21.7K
OCCI
3737
OFS Credit Co
OCCI
$70.2M
$27K ﹤0.01%
10,647
-1,835
-15% -$5.65K
WPRT
3738
Westport Fuel Systems
WPRT
$32.9M
$27K ﹤0.01%
11,731
-50
-0.4% -$100
CGC
3739
Canopy Growth
CGC
$377M
$23K ﹤0.01%
23,260
+544
+2% +$577
VFF icon
3740
Village Farms International
VFF
$250M
$23K ﹤0.01%
11,748
+500
+4% +$1.25K
MVST icon
3741
Microvast
MVST
$256M
$22K ﹤0.01%
18,465
-58,830
-76% -$90.7K
CCLD icon
3742
CareCloud
CCLD
$100M
$21K ﹤0.01%
10,000
-41,695
-81% -$108K
GEVO icon
3743
Gevo
GEVO
$363M
$19K ﹤0.01%
12,654
-1,997
-14% -$3.52K
NPWR icon
3744
NET Power
NPWR
$126M
$19K ﹤0.01%
+11,339
New +$20.5K
REAX icon
3745
Real Brokerage
REAX
$375M
$19K ﹤0.01%
+10,270
New +$20.9K
XTIA icon
3746
XTI Aerospace
XTIA
$57.3M
$19K ﹤0.01%
+10,248
New +$19.6K
CAN
3747
Canaan Creative
CAN
$178M
$18K ﹤0.01%
61,620
+23,701
+63% +$10.3K
HTZWW
3748
Hertz Global Holdings Warrants
HTZWW
$71.1M
$18K ﹤0.01%
16,414
-3,794
-19% -$9.99K
MIST icon
3749
Milestone Pharmaceuticals
MIST
$133M
$18K ﹤0.01%
13,480
-46,140
-77% -$73.8K
PLG
3750
Platinum Group Metals
PLG
$159M
$18K ﹤0.01%
13,627

Similar funds

Cambridge Investment Research Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Cambridge Investment Research Advisors held 4,210 positions worth $43.3B, up 12% from $38.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q2 2026 filing shows 286 new, 1,913 increased, 1,499 reduced and 436 closed positions. Its largest new stake was SpaceX: 259,405 shares worth $44.3M. The largest sale was FT Vest Fund of Buffer ETFs, an estimated $111M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • Cambridge Investment Research Advisors's largest Q2 2026 buy was SpaceX: 259,405 shares worth $44.3M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $126M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2026 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $73.5M.
  • Cambridge Investment Research Advisors fully exited FT Vest Fund of Buffer ETFs in Q2 2026, selling an estimated $111M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $43.3B portfolio in Q2 2026.
  • Cambridge Investment Research Advisors opened 286 new positions and closed 436 in Q2 2026.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $43.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.